Clinical characterization and identification of five novel FOXL2 pathogenic variants in a cohort of 12 Mexican subjects with the syndrome of blepharophimosis-ptosis-epicanthus inversus

• Published in: Gene Vol. 706; pp. 62 - 68
• Main Authors: Chacón-Camacho, Oscar F., Salgado-Medina, Acatzin, Alcaraz-Lares, Nayeli, López-Moreno, Daniel, Barragán-Arévalo, Tania, Nava-Castañeda, Angel, Rodríguez-Uribe, Genaro, Lieberman, Esther, Rodríguez-Cabrera, Lourdes, González-Del Angel, Ariadna, Borbolla, Ana María, Fernández-Hernández, Liliana, Graue-Hernández, Enrique O., Zenteno, Juan Carlos
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 20.07.2019
• Subjects: abnormal development; Blepharophimosis; Blepharophimosis-ptosis-epicanthus inversus; BPES; clinical examination; Epicanthus; eyelids; FOXL2; genes; genetic analysis; Mexico; mutation; patients; phenotype; Poly-alanine-tract; polymerase chain reaction; Premature ovarian failure (POF); Ptosis; Telecanthus; Mexico; SIFT; ACMG; BPES; POF; OMIM; Blepharophimosis-ptosis-epicanthus inversus; Ptosis; FOXL2; Blepharophimosis; Epicanthus; PolyPhen-2; Premature ovarian failure (POF); Telecanthus; Poly-alanine-tract
• ISSN: 0378-1119; 1879-0038; 1879-0038
• DOI: 10.1016/j.gene.2019.04.073

Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) is an autosomal dominant entity characterized by eyelid malformations and caused by mutations in the forkhead box L2 (FOXL2) gene. Clinical and genetic analyses of large cohorts of BPES patients from different ethnic origins are important for a better characterization of FOXL2 mutational landscape. The purpose of this study is to describe the phenotypic features and the causal FOXL2 variants in a Mexican cohort of BPES patients. A total of 12 individuals with typical facial findings were included. Clinical evaluation included palpebral measurements and levator function assessment. The complete coding sequence of FOXL2 was amplified by PCR and subsequently analyzed by Sanger sequencing. A total of 11 distinct FOXL2 pathogenic variants were identified in our cohort (molecular diagnostic rate of 92%), including 5 novel mutations. Our results broaden the BPES-related mutational spectrum and supports considerable FOXL2 allelic heterogeneity in our population. •First molecular analysis of FOXL2 gene in Mexican cohort with BPES syndrome•92% of all patients had heterozygous pathogenic variant.•Five novel mutations were identified.•Two changes identified may be associated to POF.